Turner A, Lanser DM, Gelli A. (2023) Optimized expression and isolation of recombinant secreted proteases using Pichia pastoris. Bio-protocol (in Press)

Vu K, Buckley BJ, Bujaroski RS, Blumwald E, Kelso MJ, Gelli A (2023) Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs. Frontiers in Cellular and Infectious Microbiology (in Press)

Spadari, CC, Lanser DM, Araujo MV, de Jesus DFF, Lopes LB, Gelli A, Ishida K (2023) Oral delivery of brain-targeted miltefosine-loaded alignate nanoparticles functionalized with polysorbate 80 for the treatment of cryptococcal meningitis. J of Antimicrobial Chemotherapy (in Press)

Bansal S*, Vu K,* Ruiwu Liu, Ajena Y, Xiao W, Menon S, Bennett A, Gelli A, Lam KS. (2022) Discovery of a potent antifungal peptide through OBOC combinatorial library screening.*Equal contribution. In press: ACS Infectious Disease, J of American Chemistry Society

Eiamcharoen P, Gelli A, Byrne B, Keel MK (2022) Characterization of Pseudogymnoascus destructans conidial adherence to extracellular matrix: Association with fungal secreted proteases and identification of extracellular matrix binding proteins. Microbial Pathogenesis (in press)

Garcia JA, Vu K, Thompson GR, Gelli A. (2022) Characterization of the growth and morphology of a BSL-2  Coccidioides posadasii strain that persists in the parasitic lifecycle at ambient CO2. bioRxiv 486294, J of Fungi, May; 8(5):455

Gelli A, Nobile JC, Pericolini E, Wellington MA (2022) Editorial: Women in Fungal Pathogenesis 2021. Frontiers in Cellular and Infection Microbiology (in press)

Vu K, Blumwald E, & Gelli A. (2021) The antifungal activity of HMA, an amiloride analog and inhibitor of Na+/H+ exchangers. Frontiers in Microbiology, 05 May 2021

Aaron PA, Vu K & Gelli A. (2020) An anti-virulence approach for preventing Cryptococcus neoformans from crossing the blood-brain barrier via novel natural product inhibitors of a fungal metalloprotease. mBio 11:e01249-20 (Journal of the American Society of Microbiology)

From the Cover: ¥Aaron, PA, Jamklang M, Uhrig JP, Gelli A. (2018) The blood-brain barrier internalizes Cryptococcus neoformans via the EphA2-tyrosine kinase receptor. Cellular Microbiology (PMCID 5836489).

Aaron PA, & Gelli A. (2020) Harnessing the activity of the fungal metalloprotease, Mpr1, to promote crossing of nanocarriers through blood-brain barrier. ACS – Infectious Diseases, Journal of the American Chemistry Society, Jan 10;6(1):138-149

Aaron PA, Vu K & Gelli A. (2020) An anti-virulence approach for preventing Cryptococcus neoformans from crossing the blood-brain barrier via novel natural product inhibitors of a fungal metalloprotease. mBio 11:e01249-20 (Journal of the American Society of Microbiology)

Na Pombejra S, Jamklang M, Uhrig JP, Vu K, Gelli A. (2018) The structure-function analysis of the Mpr1 metalloprotease determinants of activity during migration of fungal cells across the blood-brain barrier. PLOS ONE, 13(8): e0203020.

¥Vu K, Tham R, Thompson III GM, Bautos JM, Uhrig J, and Gelli A. (2014) Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. ASM MBio. 5(3)e01101-14 (PMID: 24895304) ¥Selected for Faculty1000 Prime (http://f1000.com/prime/718433707) ¥Featured as Editor’s Pick

Seminal study that identified a novel secreted metallprotease (Mpr1) required for the migration of a neurotropic fungal pathogen (Cn) into the central nervous system.